Logo 1 (58c0f4b8 D6bc 48f1 86db D4db3eee2249 02)
Ciprofloxacin Tablet, Film Coated
Product Images NDC 55154-0193
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 55154-0193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (58c0f4b8 D6bc 48f1 86db D4db3eee2249 03)
500mg Bag Label (922e9f5c Cc59 4d9e Bf42 A4b900d077ed 00)
Label for Ciprofloxacin Tablets USP 500 mg in a package of 10 tablets. Each film-coated tablet contains ciprofloxacin hydrochloride equivalent to 500 mg ciprofloxacin. The label includes storage instructions, a warning that the unit dose package is not child resistant and is intended for institutional use only, and directs to the medication guide. The product is manufactured by Unique Pharmaceutical Laboratories in India, distributed by Rising Pharma Holdings, and packaged and distributed by Major Pharmaceuticals and Cardinal Health in the USA.*
Adult Dosage Guidelines (Adult Dosage Guidelines)
A data table listing infections alongside corresponding ciprofloxacin doses, dosing frequency, and usual treatment durations. The table includes conditions such as skin and bone infections, complicated intra-abdominal infections, infectious diarrhea, typhoid fever, gonococcal infections, inhalational anthrax, plague, bacterial prostatitis, respiratory and urinary tract infections, cystitis, and sinusitis.*
Pediatric Dosage Guidelines (Pediatric Dosage Guidelines)
A table titled 'Pediatric Dosage Guidelines' showing dosing information for ciprofloxacin in children. It lists infections (Complicated Urinary Tract or Pyelonephritis, Inhalational Anthrax post-exposure, and Plague), recommended doses in mg/kg with maximum mg per dose limits, dosing frequencies (every 8 to 12 or 12 hours), and total duration of treatment in days.*
Steady Pharmacokinetic (Steady Pharmacokinetic)
A pharmacokinetic data table showing steady-state parameters for ciprofloxacin following multiple oral and intravenous doses in adults. It compares dosing regimens of 500 mg orally every 12 hours, 400 mg intravenously every 12 hours, 750 mg orally every 12 hours, and 400 mg intravenously every 8 hours. Parameters include AUC0-24h,ss (μg·h/mL) and Cmax ss (μg/mL).*
Ciprofloxacin-str1 (Ciprofloxacin Str1)
Chemical structure of ciprofloxacin hydrochloride monohydrate shown as a 2D molecular diagram with atom labels including fluorine, oxygen, nitrogen, and a carboxylic acid functional group.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
